Long-term safety and efficacy of omeprazole in gastro-oesophageal reflux disease.
Armstrong
D
D
Division of Gastroenterology, McMaster University Medical Centre, Hamilton, Ontario, Canada.
D000897:Anti-Ulcer Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001471:Barrett Esophagus / Q000209:etiology / Q000517:prevention & control; D004334:Drug Administration Schedule; D004938:Esophageal Neoplasms / Q000209:etiology / Q000517:prevention & control; D004942:Esophagitis, Peptic / Q000209:etiology / Q000517:prevention & control; D018662:Fundoplication; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology; D005755:Gastrins / Q000097:blood; D005756:Gastritis / Q000209:etiology / Q000382:microbiology; D005764:Gastroesophageal Reflux / Q000150:complications / Q000188:drug therapy* / Q000601:surgery; D016481:Helicobacter Infections / Q000150:complications; D006801:Humans; D009853:Omeprazole / Q000009:adverse effects* / Q000627:therapeutic use; D054328:Proton Pump Inhibitors; D013995:Time
D000897:Anti-Ulcer Agents; D005755:Gastrins; D054328:Proton Pump Inhibitors; D009853:Omeprazole